-
Posting Date: 12/19/2016
Medical Policy Contact Information
Medical Policy Contact Information Please Note: General inquiries related to Medicare coverage policies, drugs, radiopharmaceuticals, local and national coverage determinations, billing and reimbursement must be directed to the Provider [...]
Read More -
Posting Date: 07/18/2018
Medical Policy Contact Information
Medical Policy Contact Information Please Note: General inquiries related to Medicare coverage policies, including clinical issues, drugs, radiopharmaceuticals, local and national coverage determinations, billing and reimbursement must be [...]
Read More -
Posting Date: 07/21/2023
Tip Sheet for Medicare Providers on First Level of Appeals (Redeterminations)
Tip Sheet for Medicare Providers on First Level of Appeals (Redeterminations) If you disagree with Medicare’s claim determination, you may Appeal. However, please follow these important tips before you submit a first level of appeal [...]
Read More -
Posting Date: 07/21/2023
Tip Sheet for Medicare Providers on First Level of Appeals (Redeterminations)
Tip Sheet for Medicare Providers on First Level of Appeals (Redeterminations) If you disagree with Medicare’s claim determination, you may Appeal. However, please follow these important tips before you submit a first level of appeal [...]
Read More -
Posting Date: 07/21/2023
Tip Sheet for Medicare Providers on First Level of Appeals (Redeterminations)
Tip Sheet for Medicare Providers on First Level of Appeals (Redeterminations) If you disagree with Medicare’s claim determination, you may Appeal. However, please follow these important tips before you submit a first level of appeal [...]
Read More -
Posting Date: 10/05/2023
Billing and Coding: Bortezomib
Billing and Coding: Bortezomib drug A52371 https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid=52371 J9041, J9046, J9048, J9049, J9051
Read More -
Posting Date: 08/09/2024
Monoclonal Antibodies in Treatment of Alzheimer’s Disease - Medicare Advantage Plan Responsibility
Monoclonal Antibodies in Treatment of Alzheimer’s Disease - Medicare Advantage Plan Responsibility NCD 200.3 was issued by CMS in April,2022 and outlines Medicare coverage policy for monoclonal antibodies that target amyloid (or plaque) for [...]
Read More -
Posting Date: 08/10/2024
HETS EDI Enrollment Form User Guide
The HETS EDI Enrollment Form allows providers to attest their relationship with a 3rd party entity to exchange the ANSI X12 270/271 Beneficiary Eligibility transaction on their behalf. Table of Contents Step 1 – Authorization [...]
Read More -
Posting Date: 08/05/2024
Telehealth Place of Service 02 and 10 Clarification
Telehealth Place of Service 02 and 10 Clarification National Government Services has been receiving inquiries from providers in regard to POS 02 and POS 10 for telehealth service reporting. We’ve created this article to provide clarification. [...]
Read More